01244.HK
3D Medicines Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.46
−2.00%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
HKD 602.68M
MomentumView details →
1D Return
−2.00%
YTD Return
−53.94%
RSI (14)
49.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
HKD 602.68M
RSI (14)
49.1
MomentumView details →
1D Return
−2.00%
YTD Return
−53.94%
Similar companies
Latest newsMore news →
On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.16d ago3D Medicines announced that the arbitration award in its favor against SELLAS Life Sciences Group has been fully executed, with SELLAS ordered to pay approximately 7.983 million yuan in costs, which has been received in full.18d ago